# Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma

> **NCT00735306** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 12 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Avastin
- **DRUG:** Tarceva
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00735306
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735306, "Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00735306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*